Teva’s biosimilar, PONLIMSI™, is now FDA-approved across all indications of the reference product, Prolia ® (denosumab), to treat a variety of ...

Teva's biosimilar, PONLIMSI, is now FDA-approved across all indications of the reference product, Prolia (denosumab), to treat a variety of debilitating bone conditions.Teva's proposed biosimilar cand ...

Alongside the approval of Ponlimsi, the FDA is reviewing a BLA for TEV-45779, a biosimilar candidate for Xolair, covering all ...

Amgen stock holds above key SMAs as strong drug sales, biosimilars, and MariTide pipeline momentum offset looming patent ...

The arrival of the Wegovy pill (semaglutide), the first oral GLP-1 drug approved to treat obesity, means freedom of choice: Adults who are looking to lose weight and have at least one weight-related ...

Dear Dr. Roach: At age 48, I underwent a lumpectomy, chemo and radiation for stage I breast cancer. All is good so far, but I started experiencing osteopenia in my mid-50s, perhaps earlier than I ...

If you take Zepbound, a doctor or another healthcare professional will likely give you the first dose in their office. Then, they’ll show you or someone else how to inject Zepbound at home. You can ...

Dear Dr. Roach: At age 48, I underwent a lumpectomy, chemo and radiation for stage I breast cancer. All is good so far, but I started experiencing osteopenia in my mid-50s, perhaps earlier than I ...

KANSAS CITY, Mo. — A Kearney man accused of forcefully injecting a domestic violence victim with methamphetamine and firing gunshots at her, and then firing at law enforcement during a standoff, ...

In today’s Pharma Pulse, Eli Lilly calls for the U.K. government to overhaul its drug pricing framework and the FDA approves ...